Photo: Courtesy of Sun Pharmaceutical (http://www.sunpharma.com/media/media-kit)

2 February 2016Americas

Generic Gleevec launches in US

India-based Sun Pharmaceutical has launched its generic version of Novartis’s cancer treatment drug Gleevec (imatinib) in the US.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility